MedTrace Logo

Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids

NCT04960293 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-07-13

No results posted yet for this study

Summary

The primary purpose of this study is to compare pain after uterine artery embolization using spherical gelfoam or tris-acryl gelatin microsphere in patients with symptomatic fibroids

Conditions

  • Symptomatic Uterine Fibroids

Interventions

PROCEDURE

uterine artery embolization using spherical gelfoam

Uterine artery embolization is performed using spherical gelfoam. All other processes are same.

PROCEDURE

uterine artery embolization using tri-acryl gelatin microsphere

Uterine artery embolization is performed using tris-acryl gelatin microsphere. All other processes are same.

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Man-Deuk Kim · Department of Radiology, Severance hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-31
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04960293 on ClinicalTrials.gov